JPMorgan Chase & Co’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94K | Sell |
1,732
-8,206
| -83% | -$9.19K | ﹤0.01% | 5658 |
|
|
2025
Q1 | $11.4K | Buy |
9,938
+127
| +1% | +$146 | ﹤0.01% | 5405 |
|
|
2024
Q4 | $59.9K | Buy |
9,811
+3,024
| +45% | +$18.5K | ﹤0.01% | 4951 |
|
|
2024
Q3 | $112K | Sell |
6,787
-286
| -4% | -$4.73K | ﹤0.01% | 4676 |
|
|
2024
Q2 | $48.6K | Buy |
7,073
+1,237
| +21% | +$8.5K | ﹤0.01% | 4911 |
|
|
2024
Q1 | $56.3K | Sell |
5,836
-3,908
| -40% | -$37.7K | ﹤0.01% | 4929 |
|
|
2023
Q4 | $81K | Sell |
9,744
-4,531
| -32% | -$37.7K | ﹤0.01% | 4856 |
|
|
2023
Q3 | $119K | Buy |
14,275
+3,331
| +30% | +$27.8K | ﹤0.01% | 4507 |
|
|
2023
Q2 | $101K | Sell |
10,944
-2,856
| -21% | -$26.4K | ﹤0.01% | 4632 |
|
|
2023
Q1 | $190K | Buy |
13,800
+2,585
| +23% | +$35.6K | ﹤0.01% | 4352 |
|
|
2022
Q4 | $191K | Buy |
11,215
+223
| +2% | +$3.8K | ﹤0.01% | 4225 |
|
|
2022
Q3 | $250K | Buy |
10,992
+1,031
| +10% | +$23.4K | ﹤0.01% | 4071 |
|
|
2022
Q2 | $180K | Sell |
9,961
-1,671
| -14% | -$30.2K | ﹤0.01% | 4370 |
|
|
2022
Q1 | $312K | Buy |
11,632
+4,115
| +55% | +$110K | ﹤0.01% | 4228 |
|
|
2021
Q4 | $220K | Buy |
7,517
+862
| +13% | +$25.2K | ﹤0.01% | 4488 |
|
|
2021
Q3 | $437K | Buy |
6,655
+681
| +11% | +$44.7K | ﹤0.01% | 4038 |
|
|
2021
Q2 | $497K | Buy |
5,974
+1,561
| +35% | +$130K | ﹤0.01% | 3999 |
|
|
2021
Q1 | $338K | Buy |
4,413
+840
| +24% | +$64.3K | ﹤0.01% | 4237 |
|
|
2020
Q4 | $315K | Buy |
3,573
+927
| +35% | +$81.7K | ﹤0.01% | 3985 |
|
|
2020
Q3 | $198K | Buy |
2,646
+252
| +11% | +$18.9K | ﹤0.01% | 3738 |
|
|
2020
Q2 | $175K | Buy |
2,394
+806
| +51% | +$58.9K | ﹤0.01% | 3720 |
|
|
2020
Q1 | $89K | Sell |
1,588
-27
| -2% | -$1.51K | ﹤0.01% | 3979 |
|
|
2019
Q4 | $62K | Buy |
+1,615
| New | +$62K | ﹤0.01% | 4169 |
|